The silencing of HER2 in SKOV-3 ovarian cancer cells led to a significant increase in PTPN12 phosphatase, as identified by DNA microRNA targeting all the tyrosine phosphatases (PTPs) and dual-specificity phosphatases (DUSPs) of the human genome. Here, ERBB2 is linked to ovarian cancer.